Sectoral Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-255,271
Closed -$14.1M 109
2020
Q3
$14.1M Buy
255,271
+26,000
+11% +$1.65M 1.21% 34
2020
Q2
$14.5M Buy
229,271
+51,977
+29% +$3.57M 1.33% 32
2020
Q1
$9.06M Buy
177,294
+2,700
+2% +$181K 1.74% 20
2019
Q4
$13.9M Sell
174,594
-66,446
-28% -$3.94M 2.07% 22
2019
Q3
$11.7M Buy
241,040
+14,799
+7% +$771K 2.02% 19
2019
Q2
$11.9M Sell
226,241
-47,100
-17% -$2.71M 1.42% 26
2019
Q1
$14.5M Sell
273,341
-9,200
-3% -$452K 1.74% 19
2018
Q4
$11.6M Buy
282,541
+44,500
+19% +$1.67M 1.58% 22
2018
Q3
$9.05M Buy
238,041
+7,347
+3% +$325K 0.96% 40
2018
Q2
$10.4M Buy
230,694
+43,700
+23% +$1.99M 1.17% 34
2018
Q1
$9.03M Sell
186,994
-254,774
-58% -$14.2M 0.99% 39
2017
Q4
$17.4M Sell
441,768
-91,940
-17% -$3.43M 2.17% 19
2017
Q3
$16.6M Buy
533,708
+80,927
+18% +$2.28M 2.13% 23
2017
Q2
$12.4M Buy
452,781
+107,199
+31% +$3.19M 1.35% 29
2017
Q1
$12.7M Sell
345,582
-780,219
-69% -$19.7M 1.49% 28
2016
Q4
$16.3M Buy
1,125,801
+94,352
+9% +$1.66M 1.8% 23
2016
Q3
$23.8M Buy
1,031,449
+44,225
+4% +$843K 2.33% 18
2016
Q2
$16.4M Buy
+987,224
New +$19.9M 1.69% 26

Other funds holding GBT

Sectoral Asset Management's GBT Position: Q4 2020 in Review

Sectoral Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 255,271 shares — an estimated $14.1M sold.

Sectoral Asset Management first reported a position in GBT in Q2 2016 and held it in 18 quarters. The position peaked at $23.8M in Q3 2016. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

  • Sectoral Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Sectoral Asset Management sold 255,271 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $14.1M.
  • Sectoral Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 18 quarters.
  • Sectoral Asset Management's Global Blood Therapeutics, Inc. position peaked at $23.8M in Q3 2016.
  • 228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Sectoral Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.